pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
PUBLIC COMPANY
save

$SRRKScholar Rock Holding Corp

$SRRK46.81+1.41%
Cambridge, MA, USupdated 1d ago
Website ↗SEC EDGAR ↗Yahoo Finance ↗
community read0 votes
pipeline
3
marketed
0
phase 3
0
catalysts ytd
2
approvals ytd
0
recalls ytd
0

Pipeline(3)

pipeline depth3 products
Phase 1: 2pre_registration: 1
2Phase 11pre_registration
Phase 1
SRK-439
Obesity
Phase 1
linavonkibart
Colorectal Cancer
pre_registration
apitegromab
Spinal Muscular Atrophy (SMA)
Growth/differentiation factor 8

📅 Upcoming

no upcoming catalysts on record

🕒 Recent(90d)

earnings (1)
Aug 6, 2026
earnings
$SRRK46.81+1.41%
2mo ago
Scholar Rock Holding Corp earnings
Scholar Rock Holding Corp
→
view all catalysts →

Insider activity

source: SEC Form 4

open-market buys + sells

  • Apr 16, 26SELLHallal David· Chief Executive Officer30,615 sh @ $49.57−$1.52M↗
  • Apr 16, 26SELLVaishnaw Akshay· President of R&D12,246 sh @ $49.57−$607K↗
  • Apr 16, 26SELLSinha Vikas· Chief Financial Officer10,410 sh @ $49.57−$516K↗
  • Apr 16, 26SELLWoods Keith· Chief Operating Officer10,220 sh @ $49.57−$507K↗
routine RSU / option mechanics (6)
  • Apr 23, 26option exerciseBurow Kristina · 36,000 sh
  • Apr 23, 26option exerciseBurow Kristina · 7,800 sh
  • Apr 23, 26option exerciseBurow Kristina · 18,000 sh
  • Apr 23, 26option exerciseBurow Kristina · 28,000 sh
  • Apr 23, 26option exerciseBurow Kristina · 36,000 sh
  • Apr 23, 26option exerciseBurow Kristina · 18,000 sh
🐶 Hiring Signal
No open roles indexed yet — view Scholar Rock Holding Corp jobs →

News

no news has mentioned this company yet
identifiers
ticker
$SRRK
SEC CIK
0001727196
country
US
source
sec_tickers
top tags
Obesity2Colorectal Cancer1Melanoma1NSCLC1Oncology1
mentioned in
0news items
entity-linker matched
Data sources
SEC EDGAR
last refreshed 43m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?